gliclazide has been researched along with 5-nitro-2-(3-phenylpropylamino)benzoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kettenmann, H; Oberheim, N; Ransom, BR; Ye, ZC | 1 |
Hashimoto, M; Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y | 1 |
2 other study(ies) available for gliclazide and 5-nitro-2-(3-phenylpropylamino)benzoic acid
Article | Year |
---|---|
Pharmacological "cross-inhibition" of connexin hemichannels and swelling activated anion channels.
Topics: Amino Acids; Analysis of Variance; Angiogenesis Inhibitors; Animals; Animals, Newborn; Astrocytes; Carbenoxolone; Cell Size; Cells, Cultured; Chromatography, High Pressure Liquid; Connexin 43; Glycyrrhetinic Acid; Hippocampus; Hypotonic Solutions; Indans; Ion Channel Gating; Ion Channels; Isoquinolines; Mice; Mice, Knockout; Nitrobenzoates; Rats; Tamoxifen | 2009 |
Possible participation of chloride ion channels in ATP release from cancer cells in suspension.
Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Adhesion; Cell Line, Tumor; Chloride Channels; Fibrosarcoma; Gadolinium; Gap Junctions; Glycyrrhetinic Acid; Humans; Niflumic Acid; Nitrobenzoates; Peptides; Quinidine; Verapamil | 2009 |